Ted Ghebreyesus Lands in the DRC: A Candid Look at Ebola, Vaccines, and the Road Ahead

When Ted Ghebreyesus, the World Health Organization’s director‑general, stepped off the plane in Kinshasa last week, the humid air seemed to carry a mixture of hope and unease. He wasn’t there for a photo‑op; he was there to see, first‑hand, how the Democratic Republic of Congo (DRC) is wrestling with a fresh Ebola flare‑up that has left villages on edge.

“I wanted to meet the health workers on the front lines,” Tedros told Clarissa Ward of CNN as they walked through a bustling market, the smell of fresh plantains mingling with the distant hum of diesel generators. “Their stories matter as much as the numbers on a dashboard.”

That moment—one of conversation amid the clamor—set the tone for an interview that felt more like a dialogue than a press conference. Ward, known for her steady composure in war‑torn zones, asked the kind of questions that most officials dodge: “What do you see when you look at the health infrastructure here? Are we really ready for the next wave, or are we just hoping for the best?”

Tedros’ answers were candid, almost startlingly so. He acknowledged that while vaccine‑distribution had dramatically improved since the 2018‑2020 outbreak, gaps remain. “We now have a stockpile of the rVSV‑ZEBOV‑GP vaccine that can be deployed within days,” he said, gesturing toward a refrigerated truck parked nearby. “But logistics—roads, cold‑chain capacity, community trust—those are still the biggest hurdles.”

He spoke about the “multilayered” approach the WHO is employing: rapid case identification, contact tracing, and ring vaccination. Yet he didn’t shy away from the realities on the ground. “In some remote provinces, a health post is a two‑day hike away. If a patient develops fever, by the time they reach care, it might be too late,” he admitted, his voice softening.

Ward pressed further, noting the lingering shadows of conflict in eastern DRC. “How do you keep health initiatives afloat when armed groups sometimes target clinics?”

“It’s a dance of diplomacy and resilience,” Tedros replied. “We work closely with local NGOs, community leaders, and even, when necessary, negotiate safe passages. It’s not perfect, but it’s better than abandoning those regions.”

One surprising highlight of the visit was a brief stop at a newly opened vaccination hub in Goma. Inside, nurses, some wearing scar‑filled faces from past battles, greeted the WHO team with cautious smiles. A teenage volunteer handed Tedros a small vial of the Ebola vaccine. “This,” he said, holding it up, “is a promise that science can outpace fear.”

Yet the promise is tempered by statistics that still sting. The DRC has reported 45 confirmed cases in the past month, with a fatality rate hovering around 60 %. Those numbers, while lower than the 2019 peak, still represent real families—mothers, fathers, children—caught in a tragedy that feels both ancient and newly urgent.

When asked about the future, Tedros was pragmatic. “We need sustainable health systems, not just emergency responses. That means investing in training, building labs, and—perhaps most importantly—listening to the community’s concerns about vaccines.” He referenced a recent study showing that misinformation, often spread via WhatsApp, was the biggest barrier to vaccination uptake.

Ward, ever the storyteller, let the interview wind down with a personal note. “What keeps you going, Dr. Ghebreyesus, after years on the front lines of global health?”

He smiled, the lines around his eyes deepening. “Seeing a child receive a vaccine and the relief in a mother’s eyes—that’s why.” The camera captured the moment—a fleeting glimpse of hope amid a landscape still scarred by disease and conflict.

As the WHO delegation boarded their flight back to Geneva, the wind outside the airport’s glass doors carried the distant echo of drums. It reminded everyone present that health crises are never isolated; they ripple through culture, economics, and politics. Tedros’ visit, while brief, underscored a vital truth: combating Ebola—or any disease—requires more than medicine. It demands humility, partnership, and an unshakeable belief that humanity can, step by step, turn the tide.